Compare Novo Nordisk A/S (NVO) vs Exxon Mobil Corporation (XOM) Price & Performance

Novo Nordisk A/STrade

Exxon Mobil CorporationTrade

Price performance (Past 24H)

Key statistics

Novo Nordisk A/S vs Exxon Mobil Corporation — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Exxon Mobil Corporation trades at $151.6 (market cap $614.94B). The key difference: Exxon Mobil Corporation is far larger — about 2.8× Novo Nordisk A/S's market cap, and Novo Nordisk A/S pays the higher dividend (3.63%). Which is the better fit depends on your goals.

	NVO	XOM
Market Cap	$220.53B	$614.94B
Sector	Health	Energy
52-Week High	$71.70	$171.52
52-Week Low	$35.29	$105.83
Enterprise Value	$239.49B	$654.17B
Dividend Yield	3.63%	2.78%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Novo Nordisk A/S

No Aura AI signal available yet.

Exxon Mobil Corporation

ExxonMobil (XOM) trades at $147.39, up 0.99% today, with a bullish technical signal from moving averages and oscillators. The stock has beaten earnings estimates for the last three quarters, though revenue and net income have trended lower since 2022. Analyst consensus is a buy with a $169.78 price target, and recent news highlights the company's Permian Basin advantage and potential oil price spikes.

XOM offers value through strong cash flow and a robust balance sheet, but faces headwinds from declining profitability and net cash outflows. Investment appeal hinges on oil price stability and execution in key growth areas, while risks include volatile energy markets and execution challenges.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVO

Novo Nordisk sues Eli Lilly over misleading GLP-1 drug ads claiming superior weight-loss results.Proactive Investors · 11 hours agoBearish Novo Nordisk sues Eli Lilly over misleading ads on obesity and diabetes drug efficacy.CNBC · 15 hours agoBearish Novo Nordisk shares jump 27% on strong sales of oral Wegovy and market expansion.Seeking Alpha · 1 day agoBullish View details →

XOM

Exxon Mobil exec sells shares amid 150% stock rise and geopolitical oil risks.Stuart Mooney · 6 hours agoBullish Middle East conflict fuels energy supply shock, inflation rise, and no Fed rate cuts soonSeeking Alpha · 1 day agoBearish Pacer US Cash Cows 100 ETF rises as Brent crude spikes, boosting energy sector exposure.24/7 Wall Street · 1 day agoBullish View details →

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

About Exxon Mobil Corporation

Exxon Mobil Corporation operates petroleum and petro chemicals businesses. The Company provides operations include exploration and production of oil and gas, electric power generation, and coal and minerals operations. Exxon Mobil also manufactures and markets fuels, lubricants, and chemicals. Exxon Mobil serves customers worldwide.